Here's Why TASER International, Heron Therapeutics and Three Other Stocks Are Trading Lower on Monday
The markets have opened the fourth quarter on a negative note.
Heron Therapeutics Inc. (HRTX)
Market is closed
News
- First
- << Previous
- 41 - 50
- Next >>
What’s In The Latest Heron Therapeutics Inc (HRTX) Data?
Heron Therapeutics Inc (NASDAQ:HRTX) just announced topline from its two lead pain management phase II trials.
Healthcare-Focused Broadfin Capital's Notable Moves Include Cardiovascular Systems, Nevro Corp & Others
Kevin Kotler's healthcare-focused fund Broadfin Capital held a 13F portfolio valued at about $1.04 billion at the end of the first quarter, according to its latest filing.
Why Are Investors Piling Into These 5 Surging Stocks?
It's a day of diverging indexes as the S&P 500 is up by 0.37% while the NASDAQ is down by 0.20%. The diverging results are due to various earnings reports that affect the indexes differently.
Heron Therapeutics, Inc. (HRTX): Tang Capital Partners Raises Stake to 17%
According to a newly-amended 13D filing with the US SEC, Kevin C.
Kevin Kotler's Healthcare Fund Broadfin Capital Just Had A Disastrous Q1
Though 2016 hasn't been great for the overall hedge fund industry so far, it is turning out to be an especially terrible year for biotech-focused hedge funds.
Venrock's VHCP Management's Top Picks For 2016
At Insider Monkey, we look at the weighted average returns of the long positions a fund indicates in its 13F filings, in companies with a market cap greater than $1 billion, to estimate the returns of...
Hedge Funds Are Hoarding Shares Of Heron Therapeutics Inc (HRTX)
The latest 13F reporting period has come and gone, and Insider Monkey is again at the forefront when it comes to making use of this gold mine of data.
VHCP Management Produced Impressive Returns From Its Pharma Stock Picks In The Turbulent Third Quarter
With losses in the high single-digits and volatility hitting the roof, the third quarter of 2015 turned out to be a troublesome period for the equity markets.
Three Biotech Stocks Are Down Today but Hedge Funds Say They Are Not Out
Shares of ZIOPHARM Oncology Inc. (NASDAQ:ZIOP), Intrexon Corp (NYSE:XON), and Heron Therapeutics Inc (NASDAQ:HRTX) are down significantly today amid a broader market decline.
- First
- << Previous
- 41 - 50
- Next >>
Billionaire Hedge Funds
